← Leaderboards
Katherine B Chiappinelli
Johns Hopkins University
$3,587,162
Attributed
$4,394,822
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,394,822 · 6
By mechanism
R37$1,844,213 · 1
R01$1,281,087 · 1
R00$747,000 · 1
R21$334,233 · 1
K99$94,151 · 1
F32$94,138 · 1
Top collaborators
- Kathleen H Burns2 shared
- Reiner Strick2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Karen L. Beemon$8,952,439
- Hyam Isaac Levitsky$7,128,026
- Stephen J Gould$8,380,884
- Victor E Velculescu$5,783,536
- Kathleen H Burns$11,830,554
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsImmunotherapyResponseDna MethylationImmuneTumorT-LymphocyteEpigenetic ProcessMalignant NeoplasmsSignal TransductionCancer CellCancer Cell LineInterferonsMouse ModelGenesAffectInnovationRepetitive SequenceEpigenetic RegulationImmune ResponseDouble-Stranded RnaMethylationExhibitsMalignant Neoplasm Of Ovary
Grant awards (15)
Immunological consequences of LINE-1 expression in cancer$632,855
R01 · FY2025 · CA · contact PI
Regulation of repetitive elements in cancer by P53 and epigenetic mechanisms$371,226
R37 · FY2025 · CA · contact PI
Immunological consequences of LINE-1 expression in cancer$648,232
R01 · FY2024 · CA · contact PI
Regulation of repetitive elements in cancer by P53 and epigenetic mechanisms$352,665
R37 · FY2024 · CA · contact PI
Regulation of repetitive elements in cancer by P53 and epigenetic mechanisms$363,801
R37 · FY2023 · CA · contact PI
Regulation of repetitive elements in cancer by P53 and epigenetic mechanisms$373,701
R37 · FY2022 · CA · contact PI
Regulation of repetitive elements in cancer by P53 and epigenetic mechanisms$382,820
R37 · FY2021 · CA · contact PI
Epigenetic activation of the interferon response to sensitize cancers to immune therapy$249,000
R00 · FY2019 · CA · contact PI
Role of human endogenous retroviruses in tumor immunity of ovarian carcinoma$143,189
R21 · FY2019 · CA · contact PI
Epigenetic activation of the interferon response to sensitize cancers to immune therapy$249,000
R00 · FY2018 · CA · contact PI
Role of human endogenous retroviruses in tumor immunity of ovarian carcinoma$191,044
R21 · FY2018 · CA · contact PI
Epigenetic activation of the interferon response to sensitize cancers to immune therapy$249,000
R00 · FY2017 · CA · contact PI
Epigenetic activation of the interferon response to sensitize cancers to immune therapy$94,151
K99 · FY2016 · CA · contact PI
The use of epigenetic therapy to activate an immune response in ovarian cancer$42,608
F32 · FY2015 · CA · contact PI
The use of epigenetic therapy to activate an immune response in ovarian cancer$51,530
F32 · FY2014 · CA · contact PI